Contact Us
Drug Search Results
More Filters [+]

Sulfamethoxazole

Alternative Names: sulfamethoxazole, urobak, sulphamethoxazole, sulfametoxazol, gantanol, gantanol-ds, bactrim, sulfatrim, bactrim ds, sulmeprim, bactrim pediatric, trimeth/sulfa, septra grape, cotrim, septra, sulfamethoprim, septra ds, azo gantanol, uroplus ss, sulmeprim pediatric, cotrim d.s., sulfatrim-ds, sulfatrim-ss, sulfatrim pediatric, uroplus ds, sulfamethoprim-ds, sulfamethox-tmp ds
Latest Update: 2024-12-17
Latest Update Note: Clinical Trial Update

Product Description

Sulfamethoxazole and trimethoprim combination is used to treat infections including urinary tract infections, middle ear infections (otitis media), bronchitis, traveler's diarrhea, and shigellosis (bacillary dysentery). This medicine is also used to prevent or treat Pneumocystis jiroveci pneumonia or Pneumocystis carinii pneumonia (PCP), a very serious kind of pneumonia. (Sourced from: https://www.mayoclinic.org/drugs-supplements/sulfamethoxazole-and-trimethoprim-oral-route/description/drg-20071899)

Mechanisms of Action: FR1 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Japan | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: Pneumonia, Bacterial | Urinary Tract Infections | Pneumocystis Infections | Pneumonia, Pneumocystis | Pneumonia

Known Adverse Events: Urticaria | Anorexia

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sulfamethoxazole

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title

08/12/2024

News Article

 Locus Biosciences Announces Positive Results from Part 1 of ELIMINATE Phase 2 Trial of the Engineered Bacteriophage Therapy LBP-EC01 Published in The Lancet Infectious Diseases

08/08/2024

News Article

 Accelerate Diagnostics Announces a Successful Completion of its WAVE™ Pre-Clinical Trial

07/12/2024

News Article

 Ethyl Acetate Market Impacted by Growing Pharmaceutical Industry, Finds Maximize Market Research

01/24/2024

News Article

 Uncomplicated UTI Treatment Market Expected to Soar to US$11.9 Billion by 2030, By Persistence Market Research

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions